ScoreWhy is Spago Nanomedical AB ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.92%
EBIT Growth (5y)
-14.24%
EBIT to Interest (avg)
-38.27
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.04
Sales to Capital Employed (avg)
0.05
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.81
EV to EBIT
-2.47
EV to EBITDA
-2.49
EV to Capital Employed
89.42
EV to Sales
58.79
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3615.50%
ROE (Latest)
-166.75%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -28.3 MM
OPERATING PROFIT(Q)
Highest at SEK -6.88 MM
PRE-TAX PROFIT(Q)
Highest at SEK -5.89 MM
NET PROFIT(Q)
Highest at SEK -5.89 MM
-11What is not working for the Company
NET SALES(HY)
At SEK 0.02 MM has Grown at -98.37%
RAW MATERIAL COST(Y)
Grown by 10,596.5% (YoY
CASH AND EQV(HY)
Lowest at SEK 40.93 MM
DEBT-EQUITY RATIO
(HY)
Highest at 0 %
Here's what is working for Spago Nanomedical AB
Operating Cash Flow
Highest at SEK -28.3 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Operating Profit
Highest at SEK -6.88 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (SEK MM)
Pre-Tax Profit
Highest at SEK -5.89 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (SEK MM)
Net Profit
Highest at SEK -5.89 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (SEK MM)
Here's what is not working for Spago Nanomedical AB
Net Sales
At SEK 0.02 MM has Grown at -98.37%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (SEK MM)
Cash and Eqv
Lowest at SEK 40.93 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 10,596.5% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
